SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus
Recruiting · NCT06364930 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Recruiting | Phase 4 | 2026-03-18 | NCT06364930 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chinese University of Hong Kong | 480 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Prince of Wales Hospital | Hong Kong | Hong Kong | 81 |